Atomo Diagnostics (ASX:AT1) - Managing Director, John Kelly
Managing Director, John Kelly
Source: Atomo Diagnostics
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Atomo Diagnostics (AT1) receives approval for its COVID-19 rapid antigen test in New Zealand.
  • The test was authorised by the New Zealand Ministry of Health under the New Zealand COVID-19 Public Health Response 2020 Order
  • The authorisation covers professional and self-test use
  • Hospitals, government agencies, healthcare workers, businesses, and pharmacies are all permitted to supply, distribute, and sell the test
  • Shares are charging 17.5 per cent higher today 23.5 cents each 

Atomo Diagnostics (AT1) has received approval for its COVID-19 rapid antigen test in New Zealand.

The test was authorised by the New Zealand Ministry of Health under the New Zealand COVID-19 Public Health Response 2020 Order.

The authorisation covers professional and self-test use.

NZ District Health Board hospitals, Government agencies, the healthcare workforce, New Zealand-based businesses and pharmacies are all permitted to supply, distribute, and sell the test.

In October, the company renegotiated its supply agreement with US manufacturer Access Bio providing the right, but not the obligation, for Atomo to purchase up to 20 million COVID-19 rapid antigen tests at a fixed price per unit during CY22.

Managing Director John Kelly said he is thrilled with the approval.

“We are excited the Atomo antigen test has received approval for use in New Zealand and we have now commenced commercial discussions related to supply of the product to the New Zealand market,” he said.

Shares were charging 17.5 per cent higher today 23.5 cents each at 12:32 pm AEDT.

AT1 by the numbers
More From The Market Herald
Countplus (ASX:CUP) - Incoming CEO, Hugh Humphrey

" Hugh Humphrey appointed CEO of Countplus (ASX:CUP)

Investment services company CountPlus (ASX:CUP) has appointed Hugh Humphrey as the company's CEO, effective July 1.

" ASX employee tests positive for Covid-19

The ASX says an employee has contracted Covid-19.

" ASIC launches official investigation into ASX market outage

The ASX has confirmed today it is officially under investigation from the Australian Securities and Investments…

" ASX sheds more light on last week’s market tech failure

The Australian Securities Exchange has shed some more light on the nature of last week's market…